Lunsumio 50242-0159-01
Generic: Mosunetuzumab
- Manufacturer
- Genentech, Inc.
- Dosage Form
- Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 22, 2022
- Listing Expires
- December 31, 2026
- Application
- BLA761263
Need to source Lunsumio? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mosunetuzumab | 1 mg/mL |
Selected Package
50242-0159-01Selected1 VIAL in 1 CARTON (50242-159-01) / 1 mL in 1 VIAL